BusinessVelano Vascular Named 2018’s Gold Edison Award™ WinnerBy Nasdaq OMXApr 17, 2018, 12:00 PM UTC
BusinessVelano Vascular to Address Healthcare Innovation at Upcoming Spring ConferencesBy Nasdaq OMXApr 10, 2018, 12:00 PM UTC
BusinessProteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) ConferenceBy Nasdaq OMXOct 25, 2016, 12:02 PM UTC
BusinessProteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) ConferenceBy Nasdaq OMXOct 25, 2016, 12:02 PM UTC
BusinessProteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery DiseaseBy Nasdaq OMXApr 13, 2016, 12:00 PM UTC
